Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

These 4 New Funds Hold A Lot Of Promise

In the expanding universe of exchange-traded funds (ETFs), it’s sink or swim.

Any ETFs that fail to gain a big enough investor following eventually are shut down. It simply costs too much to operate fund that only has a few million dollars and trades only a few thousand shares every day.

Yet for every ETF that disappears from the market, a new one is launched. Of course, some of these ETFs are simply “me too” products that merely replicate the composition and performance of the most popular funds. At this point, do investors really need yet another ETF that mimics the S&P 500 Index?

That’s why ETF sponsors are trying to come up with new angles, launching funds that capitalize on key investing themes that haven’t been covered by other ETFs. In the past few months, we’ve seen several solid new ETFs that you should know more about. They may take time to build up assets, but they hold a great deal of long-term promise.

1. ProShares S&P 500 Aristocrats ETF (NYSEARCA:NOBL)

We’re big fans of companies that have built a long-term track record of dividend payments. And that’s what you’ll get with this ETF, which owns stocks in companies that have boosted their dividends for at least 25 years in a row. The track record is undeniably impressive: An index developed by S&P that underpins this ETF has gained 14% a year, on average, over the past five years, handily beating the S&P 500’s 10% annualized gain.

Leveraged ETF

I wrote about these “aristocrats” earlier this year, noting that these stocks also tend to deliver above-average dividend yields, not just solid dividend growth. That’s a great reason to own this ETF. But investors shouldn’t necessarily anticipate continued outperformance with this approach. As I wrote back in February, rising interest rates will eventually lead more investors to buy bonds and CDs, “which will draw some attention away from dividend-paying stocks.”

2. WisdomTree Trust (NASDAQ:EMCG)

This ETF resolves a long-standing conundrum. Many emerging-market stocks are actually much more closely tied to Europe and the U.S. than local economies. The iShares MSCI Emerging Markets Indx (ETF) (NYSEARCA:EEM), for example, counts companies such as Samsung, Taiwan Semiconductor and Hyundai Motors among its top 10 holdings. It’s a challenge I noted roughly a year ago:

“An investment in emerging markets is really an indirect proxy for developed markets. Even large emerging-market companies that have greater local exposure are often still tied to global pricing trends. I’m talking about the commodity producers, major banks and basic materials firms.”

That’s why this new ETF is so appealing. It focuses on companies selling into the fast-rising emerging-markets middle class. The fund’s assets have a 31% weighting in consumer discretionary stocks, 27% in consumer staple stocks, 18% in banks and insurers, and 10% in utilities. China, Brazil and South Africa account for roughly 40% of the portfolio, while Mexico, India, Indonesia and Turkey make up another 33%.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.